Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nitroreductases (NTRs) are a family of oxidoreductase enzymes, primarily found in bacteria, that catalyze the reduction of nitroaromatic and nitroheterocyclic compounds. These enzymes use NAD(P)H as an electron donor to reduce nitro groups on substrates, often resulting in the activation of prodrugs or the detoxification/biotransformation of environmental pollutants. Engineered forms of NTRs are used in cancer gene therapy to selectively activate chemotherapeutics within tumor microenvironments.
Catalyzes the reduction of nitroaromatic and nitroheterocyclic compounds, activating prodrugs into cytotoxic metabolites.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nitroreductase (NTR).